Status:
UNKNOWN
Effect of Perioperative Oral Pregabalin in Total Knee Replacement
Lead Sponsor:
Bahrain Defence Force Hospital
Conditions:
Postoperative Pain
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
This interventional randomized control trial aim to determine efficacy and safety of Oral pregabalin in improving after surgery pain control in patients undergoing total knee replacement surgeries und...
Detailed Description
After obtaining approval from the institutional ethical committee and informed written consent, 120 patients fulfilling the inclusion criteria will be included in this study. The patients will be rand...
Eligibility Criteria
Inclusion
- Age between 18 to 85 year
- Elective Regional anesthesia.
- Able to follow study protocol
Exclusion
- ASA -IV
- Age \<18 \& \> 85 years
- Patients on pregabalin for chronic neuropathic pain.
- Patient under General anesthesia
- Patients with chronic liver failure
- Patients with chronic renal failure on Hemodialysis
- Patients on opioid (\>3 month)
- Patient with complicated knee surgery
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06187922
Start Date
September 1 2023
End Date
July 30 2025
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bahrain Defence Force
Manama, Bahrain, 323